{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:43:30Z","timestamp":1791269010650,"version":"4.1.0"},"reference-count":47,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Stage at cancer diagnosis is an important predictor of cancer survival. TNM stage is constructed for anatomic solid cancer diagnoses from tumor size (T), nodal spread (N) and distant metastasis (M) and categorized in groups 0\u2013I, II, II and IV. TNM stage is imperative in cancer diagnosis, management and control, and of high value in cancer surveillance, for example, monitoring of stage distributions. This study yields an overview of TNM availability and trends in stage distribution in the Nordic countries for future use in monitoring and epidemiologic studies.\nMaterial and methods: TNM information was acquired from the cancer registries in Denmark, Norway, Sweden, and Iceland during 2004\u20132016 for 26 cancer sites in the three former countries and four in Iceland. We studied availability, comparability, and distribution of TNM stage in three periods: 2004\u20132008, 2009\u20132013, and 2014\u20132016, applying a previously validated algorithm of \u2018N0M0 for NXMX\u2019. For cancers of colon, rectum, lung, breast, and kidney, we examined TNM stage-specific 1-year relative survival to evaluate the quality in registration of TNM between countries.\nResults: Denmark, Sweden, and Iceland exhibited available TNM stage proportions of 75\u201395% while proportions were lower in Norway. Proportions increased in Sweden over time but decreased in Denmark. One-year relative survival differed substantially more between TNM stages than between countries emphasizing that TNM stage is an important predictor for survival and that stage recording is performed similarly in the Nordic countries.\nInterpretation: Assessment and registration of TNM stage is an imperative tool in evaluations of trends in cancer survival between the Nordic countries.<\/jats:p>","DOI":"10.2340\/1651-226x.2024.35232","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:50:12Z","timestamp":1715136612000},"page":"303-312","source":"Crossref","is-referenced-by-count":16,"title":["TNM stage in the Nordic Cancer Registries 2004\u20132016: Registration and availability"],"prefix":"10.2340","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5337-6234","authenticated-orcid":false,"given":"Gerda","family":"Engholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-7178","authenticated-orcid":false,"given":"Frida E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"K\u00f8nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00ednborg","family":"\u00d3lafsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom B.","family":"Johannesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nea","family":"Malila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina S.","family":"M\u00f8rch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-7231","authenticated-orcid":false,"given":"Anna L.V.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"59490","doi-asserted-by":"crossref","unstructured":"Kerr DJ, Haller DG, van de Velde CJH, Baumann M, eds. Oxford textbook of oncology, 3th ed. New York (NY): Oxford University Press; 2016.","DOI":"10.1093\/med\/9780199656103.001.0001"},{"key":"59491","doi-asserted-by":"crossref","unstructured":"Brierley J, O\u2019Sullivan B, Asamura H, Byrd D, Huang SH, Lee A, et al. Global Consultation on Cancer Staging: promoting consistent understanding and use. Nat Rev Clin Oncol. 2019;16(12):763\u2013771.","DOI":"10.1038\/s41571-019-0253-x"},{"key":"59492","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41571-019-0253-x","DOI":"10.1038\/s41571-019-0253-x"},{"key":"59493","doi-asserted-by":"crossref","unstructured":"Engholm G, Lundberg FE, K\u00f8nig SM, \u00d3lafsd\u00f3ttir E, Johannesen TB, Pettersson D, et al. Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data. Acta Oncol. 2023;62(3):215\u2013222.","DOI":"10.1080\/0284186X.2023.2189528"},{"key":"59494","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2023.2189528","DOI":"10.1080\/0284186X.2023.2189528"},{"key":"59495","doi-asserted-by":"crossref","unstructured":"Pukkala E, Engholm G, H\u00f8jsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic Cancer Registries \u2013 an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440\u2013455.","DOI":"10.1080\/0284186X.2017.1407039"},{"key":"59496","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2017.1407039.","DOI":"10.1080\/0284186X.2017.1407039"},{"key":"59497","doi-asserted-by":"crossref","unstructured":"Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN \u2013 a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725\u2013736.","DOI":"10.3109\/02841861003782017"},{"key":"59498","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/02841861003782017","DOI":"10.3109\/02841861003782017"},{"key":"59499","unstructured":"Lar\u00f8nningen S, Arvidsson G, Bray F, Engholm G, Ervik M, Gu\u00f0mundsd\u00f3ttir EM, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, Version 9.3 (02.10.2023). Association of the Nordic Cancer Registries. Cancer Registry of Norway; 2023 [cited 2023 Dec 02] Available from: https:\/\/nordcan.iarc.fr\/"},{"key":"59500","doi-asserted-by":"crossref","unstructured":"Lar\u00f8nningen S, Skog A, Engholm G, Ferlay J, Johannesen TB, Kristiansen MF, et al. Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data. Front. Oncol. 2023;13:1098342.","DOI":"10.3389\/fonc.2023.1098342"},{"key":"59501","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fonc.2023.1098342","DOI":"10.3389\/fonc.2023.1098342"},{"key":"59502","doi-asserted-by":"crossref","unstructured":"Storm HH, Engholm G, Hakulinen T, Tryggvad\u00f3ttir L, Klint A, Gislum M, et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999\u20132003 followed to the end of 2006. A critical overview of the results. Acta Oncol. 2010;49(5):532\u2013544.","DOI":"10.3109\/02841861003801148"},{"key":"59503","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/02841861003801148","DOI":"10.3109\/02841861003801148"},{"key":"59504","doi-asserted-by":"crossref","unstructured":"Lundberg FE, Andersson TM, Lambe M, Engholm G, M\u00f8rch LS, Johannesen TB, et al. Trends in cancer survival in the Nordic countries 1990\u20132016: the NORDCAN survival studies. Acta Oncol. 2020;59(11):1266\u20131274.","DOI":"10.1080\/0284186X.2020.1822544"},{"key":"59505","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2020.1822544","DOI":"10.1080\/0284186X.2020.1822544"},{"key":"59506","doi-asserted-by":"crossref","unstructured":"Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42\u201345.","DOI":"10.1177\/1403494810393562"},{"key":"59507","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1403494810393562","DOI":"10.1177\/1403494810393562"},{"key":"59508","doi-asserted-by":"crossref","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u2013490.","DOI":"10.2147\/CLEP.S91125"},{"key":"59509","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2147\/CLEP.S91125","DOI":"10.2147\/CLEP.S91125"},{"key":"59510","doi-asserted-by":"crossref","unstructured":"Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39:72\u201374.","DOI":"10.1177\/1403494810393563"},{"key":"59511","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1403494810393563","DOI":"10.1177\/1403494810393563"},{"key":"59512","doi-asserted-by":"crossref","unstructured":"Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(7 Suppl):26\u201329.","DOI":"10.1177\/1403494811399958"},{"key":"59513","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1403494811399958","DOI":"10.1177\/1403494811399958"},{"key":"59514","doi-asserted-by":"crossref","unstructured":"Nilbert M, Thomsen LA, Winther Jensen J, M\u00f8ller H, Borre M, Widenlou Nordmark A, et al. The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care. Acta Oncol. 2020;59(11):1343\u20131356.","DOI":"10.1080\/0284186X.2020.1820573"},{"key":"59515","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2020.1820573","DOI":"10.1080\/0284186X.2020.1820573"},{"key":"59516","unstructured":"Om INCA (In Swedish). [cited 2023 Aug 31]. Available from: https:\/\/cancercentrum.se\/mellansverige\/vara-uppdrag\/kunskapsstyrning\/kvalitetsregister\/om-inca\/"},{"key":"59517","unstructured":"Registration and Research>Quality registration of Cancer. [cited 2023 Dec 19]. Available from: https:\/\/www.krabb.is\/rannsoknasetur\/en"},{"key":"59518","unstructured":"Sobin LH, Wittekind C, eds. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: John Wiley & Sons, Inc.; 1997."},{"key":"59519","doi-asserted-by":"crossref","unstructured":"Sobin LH, Wittekind C, eds. TNM Classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002.","DOI":"10.1002\/0471463752"},{"key":"59520","doi-asserted-by":"crossref","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours, 7th ed. Chichester: Wiley; 2009.","DOI":"10.1002\/9780471420194.tnmc26"},{"key":"59521","doi-asserted-by":"crossref","unstructured":"Rutherford MJ, Dickman PW, Coviello E, Lambert PC. Estimation of age-standardized net survival, even when age-specific data are sparse. Cancer Epidemiol. 2020;67:101745.","DOI":"10.1016\/j.canep.2020.101745"},{"key":"59522","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.canep.2020.101745","DOI":"10.1016\/j.canep.2020.101745"},{"key":"59523","unstructured":"Lambert P. STPP: Stata module to compute Pohar-Perme non-parametric estimate of marginal relative (net) survival. Statistical Software Components S458743. Boston College Department of Economics; Boston; 2020 Revised 05 January 2024."},{"key":"59524","doi-asserted-by":"crossref","unstructured":"Meyer HJ, Pfeil A, Schramm D, Bach AG, Surov A. Renal incidental findings on computed tomography: Frequency and distribution in a large non selected cohort. Medicine (Baltimore). 2017 Jun;96(26):e7039.","DOI":"10.1097\/MD.0000000000007039"},{"key":"59525","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/MD.0000000000007039","DOI":"10.1097\/MD.0000000000007039"},{"key":"59526","unstructured":"DARENCA data yearly report 1\/8\/2015-31\/7\/2016 (In Danish) Page 82. [cited 2023 Sep 01]. Available from: https:\/\/ducg.dk\/fileadmin\/www.ducg.dk\/Nyrecancer\/DaRenCa_AArsrapport_2016_Offentliggoerelse_3_0.pdf"},{"key":"59527","doi-asserted-by":"crossref","unstructured":"Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians \u2013 a national Danish project. Health Policy. 2012 Apr;105(1):65\u201370.","DOI":"10.1016\/j.healthpol.2011.11.001"},{"key":"59528","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.healthpol.2011.11.001","DOI":"10.1016\/j.healthpol.2011.11.001"},{"key":"59529","doi-asserted-by":"crossref","unstructured":"Dyrop HB, Safwat A, Vedsted P, Maretty-Nielsen K, Hansen BH, J\u00f8rgensen PH, et al. Cancer patient pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark. Health Policy. 2013 Nov;113(1\u20132):110\u2013117.","DOI":"10.1016\/j.healthpol.2013.09.012"},{"key":"59530","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.healthpol.2013.09.012","DOI":"10.1016\/j.healthpol.2013.09.012"},{"key":"59531","doi-asserted-by":"crossref","unstructured":"Nilssen Y, Brustugun OT, Tandberg Eriksen M, Gulbrandsen J, Skaaheim Haug E, Naume B, et al. Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway. Cancer Epidemiol. 2019 Aug;61:59\u201369.","DOI":"10.1016\/j.canep.2019.05.004"},{"key":"59532","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.canep.2019.05.004","DOI":"10.1016\/j.canep.2019.05.004"},{"key":"59533","doi-asserted-by":"crossref","unstructured":"Lundberg FE, Kroman N, Lambe M, Andersson TM, Engholm G, Johannesen TB, et al. Age-specific survival trends and life-years lost in women with breast cancer 1990\u20132016: the NORDCAN survival studies. Acta Oncol. 2022;61(12):1481\u20131489.","DOI":"10.1080\/0284186X.2022.2156811"},{"key":"59534","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2022.2156811","DOI":"10.1080\/0284186X.2022.2156811"},{"key":"59535","doi-asserted-by":"crossref","unstructured":"Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun;312(25):1604\u20131608.","DOI":"10.1056\/NEJM198506203122504"},{"key":"59536","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJM198506203122504","DOI":"10.1056\/NEJM198506203122504"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/35232\/46073","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/35232\/46073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:05:14Z","timestamp":1756404314000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/35232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":47,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2024.35232","relation":{},"ISSN":["1651-226X","0284-186X"],"issn-type":[{"value":"1651-226X","type":"electronic"},{"value":"0284-186X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}